Singapore healthcare stocks: no more a defensive play as pandemic boost fades
Megan Cheah
SINGAPORE-LISTED healthcare players have witnessed retreating earnings and share prices this year, but analysts said that they continue to see good prospects for select stocks.
The iEdge Singapore All Healthcare Index delivered total returns of minus 2.5 per cent in the year to Monday (Nov 6). In comparison, the benchmark Straits Times Index was up 2.3 per cent over the same period.
These stocks may be correcting from their pandemic highs. The index generated total returns of 70.3 per cent in 2020, against an 8.1 per cent decline for the bourse’s blue-chip barometer.
TRENDING NOW
Tiger Brokers, Moomoo, Longbridge Singapore units ‘financially independent’ amid China crackdown: MAS
Yeo’s, Tiger Beer and now Gardenia – flight of food manufacturing from Singapore might be just as planned
Johor property old hand KSL readies family handover amid market boom
As India and China surge ahead with nuclear energy, all eyes on Asean’s next move